IR@PKUHSC  > 北京大学第三临床医学院  > 肾内科
学科主题临床医学
End-stage kidney disease due to haemolytic uraemic syndrome - outcomes in 241 consecutive ANZDATA registry cases
Tang, Wen1,2,3; Mohandas, Janaki1,3; McDonald, Stephen P.1,4,5; Hawley, Carmel M.1,3; Badve, Sunil V.1,3; Boudville, Neil1,6; Brown, Fiona G.1,7; Clayton, Philip A.1,8,9; Wiggins, Kathryn J.1,10; Bannister, Kym M.1; Campbell, Scott B.1,3; Johnson, David W.1,3,11
关键词Haemolytic Uraemic Syndrome Kidney Failure Chronic Outcomes Renal Function Recovery Renal Transplantation Thrombotic Microangiopathy
刊名BMC NEPHROLOGY
2012-12-03
DOI10.1186/1471-2369-13-164
13
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Urology & Nephrology
研究领域[WOS]Urology & Nephrology
关键词[WOS]THROMBOTIC THROMBOCYTOPENIC PURPURA ; RENAL-FUNCTION ; PERITONEAL-DIALYSIS ; COMPETING RISKS ; RECOVERY ; FAILURE ; TRANSPLANTATION ; DEFICIENCY ; DISORDERS ; HUS
英文摘要

Background: The aim of this study was to investigate the characteristics and outcomes of patients receiving renal replacement therapy for end-stage kidney disease (ESKD) secondary to haemolytic uraemic syndrome (HUS).

Methods: The study included all patients with ESKD who commenced renal replacement therapy in Australia and New Zealand between 15/5/1963 and 31/12/2010, using data from the ANZDATA Registry. HUS ESKD patients were compared with matched controls with an alternative primary renal disease using propensity scores based on age, gender and treatment era. Results: Of the 58422 patients included in the study, 241 (0.4%) had ESKD secondary to HUS. HUS ESKD was independently associated with younger age, female gender and European race. Compared with matched controls, HUS ESKD was not associated with mortality on renal replacement therapy (adjusted hazard ratio [HR] 1.14, 95% CI 0.87-1.50, p = 0.34) or dialysis (HR 1.34, 95% CI 0.93-1.93, p = 0.12), but did independently predict recovery of renal function (HR 54.01, 95% CI 1.45-11.1, p = 0.008). 130 (54%) HUS patients received 166 renal allografts. Overall renal allograft survival rates were significantly lower for patients with HUS ESKD at 1 year (73% vs 91%), 5 years (62% vs 85%) and 10 years (49% vs 73%). HUS ESKD was an independent predictor of renal allograft failure (HR 2.59, 95% CI 1.70-3.95, p < 0.001). Sixteen (12%) HUS patients experienced failure of 22 renal allografts due to recurrent HUS. HUS ESKD was not independently associated with the risk of death following renal transplantation (HR 0.92, 95% CI 0.35-2.44, p = 0.87).

Conclusions: HUS is an uncommon cause of ESKD, which is associated with comparable patient survival on dialysis, an increased probability of renal function recovery, comparable patient survival post-renal transplant and a heightened risk of renal transplant graft failure compared with matched ESKD controls.

语种英语
WOS记录号WOS:000313589100001
引用统计
被引频次:7[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/56675
专题北京大学第三临床医学院_肾内科
作者单位1.Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia
2.Royal Melbourne Hosp, Dept Nephrol, Parkville, Vic 3050, Australia
3.Princess Alexandra Hosp, Dept Renal Med, Brisbane, Qld 4102, Australia
4.ANZDATA Registry, Adelaide, SA, Australia
5.Peking Univ, Hosp 3, Div Nephrol, Beijing 100871, Peoples R China
6.Univ Queensland, Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia
7.Univ Adelaide, Cent No Adelaide Renal Serv, Dept Nephrol & Transplantat Serv, Adelaide, SA, Australia
8.Univ Adelaide, Cent No Adelaide Transplantat Serv, Dept Nephrol & Transplantat Serv, Adelaide, SA, Australia
9.Univ Western Australia, Sir Charles Gairdner Hosp Unit, Sch Med & Pharmacol, Perth, WA 6009, Australia
10.Monash Med Ctr, Dept Nephrol, Melbourne, Vic, Australia
11.Royal Prince Alfred Hosp, Dept Renal Med, Sydney, NSW, Australia
推荐引用方式
GB/T 7714
Tang, Wen,Mohandas, Janaki,McDonald, Stephen P.,et al. End-stage kidney disease due to haemolytic uraemic syndrome - outcomes in 241 consecutive ANZDATA registry cases[J]. BMC NEPHROLOGY,2012,13.
APA Tang, Wen.,Mohandas, Janaki.,McDonald, Stephen P..,Hawley, Carmel M..,Badve, Sunil V..,...&Johnson, David W..(2012).End-stage kidney disease due to haemolytic uraemic syndrome - outcomes in 241 consecutive ANZDATA registry cases.BMC NEPHROLOGY,13.
MLA Tang, Wen,et al."End-stage kidney disease due to haemolytic uraemic syndrome - outcomes in 241 consecutive ANZDATA registry cases".BMC NEPHROLOGY 13(2012).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Tang, Wen]的文章
[Mohandas, Janaki]的文章
[McDonald, Stephen P.]的文章
百度学术
百度学术中相似的文章
[Tang, Wen]的文章
[Mohandas, Janaki]的文章
[McDonald, Stephen P.]的文章
必应学术
必应学术中相似的文章
[Tang, Wen]的文章
[Mohandas, Janaki]的文章
[McDonald, Stephen P.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。